These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25376718)

  • 1. Qualitative and quantitative aspects of information processing in first psychosis: latent class analyses in patients, at-risk subjects, and controls.
    van Tricht MJ; Bour LJ; Koelman JH; Derks EM; Braff DL; de Wilde OM; Boerée T; Linszen DH; de Haan L; Nieman DH
    Psychophysiology; 2015 Apr; 52(4):585-93. PubMed ID: 25376718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditory ERP components before and after transition to a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JH; Bour LJ; van der Meer JN; van Amelsvoort TA; Linszen DH; de Haan L
    Biol Psychol; 2011 Jul; 87(3):350-7. PubMed ID: 21536095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations.
    Hermens DF; Ward PB; Hodge MA; Kaur M; Naismith SL; Hickie IB
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):822-9. PubMed ID: 20302901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JT; Mensink AJ; Bour LJ; van der Meer JN; van Amelsvoort TA; Linszen DH; de Haan L
    World J Biol Psychiatry; 2015 Jan; 16(1):12-21. PubMed ID: 22730901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study of event related potentials and correlations with psychosocial functioning and clinical features in first episode psychosis patients.
    Monaghan CK; Brickman S; Huynh P; Öngür D; Hall MH
    Int J Psychophysiol; 2019 Nov; 145():48-56. PubMed ID: 31108121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced prepulse inhibition as an early vulnerability marker of the psychosis prodrome in adolescence.
    Ziermans TB; Schothorst PF; Sprong M; Magnée MJ; van Engeland H; Kemner C
    Schizophr Res; 2012 Jan; 134(1):10-5. PubMed ID: 22085828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.
    Thompson A; Papas A; Bartholomeusz C; Allott K; Amminger GP; Nelson B; Wood S; Yung A
    Schizophr Res; 2012 Nov; 141(2-3):204-9. PubMed ID: 22959742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls.
    van Tricht MJ; Harmsen EC; Koelman JH; Bour LJ; van Amelsvoort TA; Linszen DH; de Haan L; Nieman DH
    Int J Psychophysiol; 2013 May; 88(2):149-56. PubMed ID: 23541998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auditory event-related potential of subjects with suspected pre-psychotic state and first-episode psychosis.
    Hsieh MH; Shan JC; Huang WL; Cheng WC; Chiu MJ; Jaw FS; Hwu HG; Liu CC
    Schizophr Res; 2012 Sep; 140(1-3):243-9. PubMed ID: 22784684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multimodal approach to investigate biomarkers for psychosis in a clinical setting: the integrative neuroimaging studies in schizophrenia targeting for early intervention and prevention (IN-STEP) project.
    Koike S; Takano Y; Iwashiro N; Satomura Y; Suga M; Nagai T; Natsubori T; Tada M; Nishimura Y; Yamasaki S; Takizawa R; Yahata N; Araki T; Yamasue H; Kasai K
    Schizophr Res; 2013 Jan; 143(1):116-24. PubMed ID: 23219075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental factors and social adjustment as predictors of a first psychosis in subjects at ultra high risk.
    Dragt S; Nieman DH; Veltman D; Becker HE; van de Fliert R; de Haan L; Linszen DH
    Schizophr Res; 2011 Jan; 125(1):69-76. PubMed ID: 20884179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperament and character in individuals at ultra-high risk for psychosis and with first-episode schizophrenia: associations with psychopathology, psychosocial functioning, and aspects of psychological health.
    Song YY; Kang JI; Kim SJ; Lee MK; Lee E; An SK
    Compr Psychiatry; 2013 Nov; 54(8):1161-8. PubMed ID: 23831396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
    Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced visual P300 amplitudes in individuals at ultra-high risk for psychosis and first-episode schizophrenia.
    Lee SY; Namkoong K; Cho HH; Song DH; An SK
    Neurosci Lett; 2010 Dec; 486(3):156-60. PubMed ID: 20858531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome.
    Simon AE; Grädel M; Cattapan-Ludewig K; Gruber K; Ballinari P; Roth B; Umbricht D
    Schizophr Res; 2012 Dec; 142(1-3):108-15. PubMed ID: 23025995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls.
    Pruessner M; Iyer SN; Faridi K; Joober R; Malla AK
    Schizophr Res; 2011 Jun; 129(1):29-35. PubMed ID: 21497058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.